Robert Langer, 10% Owner at INVIVO THERAPEUTICS HOLDINGS CORP. (NVIV), sold 7,500 shares at $2.99 ($23K) on 2013-04-29, disclosed to the SEC on 2013-05-01.
Scheduled sale ($23k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.99 | 2,500 | $7K | 32.0% |
| 2 | $3.19 | 2,500 | $8K | 34.1% |
| 3 | $3.17 | 2,500 | $8K | 33.9% |
| Total | $3.12 avg | 7,500 | $23K | 100% |
| Filing → |
| RUBY | SELL | 2019-04-17 | $132K | — | Filing → |
| RUBY | SELL | 2019-01-18 | $109K | — | Filing → |
| NVIV | SELL | 2013-06-05 | $28K | — | Filing → |